|
1
|
Delmonico MJ, Harris TB, Visser M, Park
SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M,
Newman AB and Goodpaster BH: Health, Aging, and Body: Longitudinal
study of muscle strength, quality, and adipose tissue infiltration.
Am J Clin Nutr. 90:1579–1585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Xu S, Zhang X, Yi Z and Cichello S:
Skeletal intramyocellular lipid metabolism and insulin resistance.
Biophys Rev. 1:90–98. 2015.
|
|
3
|
Skipworth RJE, Stewart GD, Dejong CHC,
Preston T and Fearon KCH: Pathophysiology of cancer cachexia: Much
more than host-tumour interaction? Clin Nutr. 26:667–676. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dewys WD, Begg C, Lavin PT, Band PR,
Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF,
Ezdinli EZ, et al: Eastern Cooperative Oncology Group: Prognostic
effect of weight loss prior to chemotherapy in cancer patients. Am
J Med. 69:491–497. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fearon KCH, Voss AC and Hustead DS: Cancer
Cachexia Study Group: Definition of cancer cachexia: Effect of
weight loss, reduced food intake, and systemic inflammation on
functional status and prognosis. Am J Clin Nutr. 83:1345–1350.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lieffers JR, Bathe OF, Fassbender K,
Winget M and Baracos VE: Sarcopenia is associated with
postoperative infection and delayed recovery from colorectal cancer
resection surgery. Br J Cancer. 107:931–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding Q, Mracek T, Gonzalez-Muniesa P, Kos
K, Wilding J, Trayhurn P and Bing C: Identification of macrophage
inhibitory cytokine-1 in adipose tissue and its secretion as an
adipokine by human adipocytes. Endocrinology. 150:1688–1696. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Russell ST and Tisdale MJ: The role of
glucocorticoids in the induction of zinc-alpha2-glycoprotein
expression in adipose tissue in cancer cachexia. Br J Cancer.
92:876–881. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mracek T, Stephens NA, Gao D, Bao Y, Ross
JA, Rydén M, Arner P, Trayhurn P, Fearon KC and Bing C: Enhanced
ZAG production by subcutaneous adipose tissue is linked to weight
loss in gastrointestinal cancer patients. Br J Cancer. 104:441–447.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Das SK, Eder S, Schauer S, Diwoky C,
Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner
M, et al: Adipose triglyceride lipase contributes to
cancer-associated cachexia. Science. 333:233–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gray C, MacGillivray TJ, Eeley C, Stephens
NA, Beggs I, Fearon KCH and Greig CA: Magnetic resonance imaging
with k-means clustering objectively measures whole muscle volume
compartments in sarcopenia/cancer cachexia. Clin Nutr. 30:106–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stephens NA, Skipworth RJE, Macdonald AJ,
Greig CA, Ross JA and Fearon KCH: Intramyocellular lipid droplets
increase with progression of cachexia in cancer patients. J
Cachexia Sarcopenia Muscle. 2:111–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mueller TC, Bachmann J, Prokopchuk O,
Friess H and Martignoni ME: Molecular pathways leading to loss of
skeletal muscle mass in cancer cachexia - can findings from animal
models be translated to humans? BMC Cancer. 16:752016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fearon KCH and Baracos VE: Cachexia in
pancreatic cancer: New treatment options and measures of success.
HPB. 12:323–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Skipworth RJE, Stewart GD, Bhana M,
Christie J, Sturgeon CM, Guttridge DC, Cronshaw AD, Fearon KCH and
Ross JA: Mass spectrometric detection of candidate protein
biomarkers of cancer cachexia in human urine. Int J Oncol.
36:973–982. 2010.PubMed/NCBI
|
|
16
|
Husi H, Stephens N, Cronshaw A, MacDonald
A, Gallagher I, Greig C, Fearon KCH and Ross JA: Proteomic analysis
of urinary upper gastrointestinal cancer markers. Proteomics Clin
Appl. 5:289–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prado CM, Lieffers JR, McCargar LJ, Reiman
T, Sawyer MB, Martin L and Baracos VE: Prevalence and clinical
implications of sarcopenic obesity in patients with solid tumours
of the respiratory and gastrointestinal tracts: A population-based
study. Lancet Oncol. 9:629–635. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodpaster BH, Thaete FL and Kelley DE:
Composition of skeletal muscle evaluated with computed tomography.
Ann N Y Acad Sci. 904:18–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goodpaster BH, Carlson CL, Visser M,
Kelley DE, Scherzinger A, Harris TB, Stamm E and Newman AB:
Attenuation of skeletal muscle and strength in the elderly: The
Health ABC Study. J Appl Physiol 1985. 90:2157–2165. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin L, Birdsell L, Macdonald N, Reiman
T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB and
Baracos VE: Cancer cachexia in the age of obesity: Skeletal muscle
depletion is a powerful prognostic factor, independent of body mass
index. J Clin Oncol. 31:1539–1547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hosokawa M, Kashiwaya K, Eguchi H,
Ohigashi H, Ishikawa O, Furihata M, Shinomura Y, Imai K, Nakamura Y
and Nakagawa H: Over-expression of cysteine proteinase inhibitor
cystatin 6 promotes pancreatic cancer growth. Cancer Sci.
99:1626–1632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dencker M, Tanha T, Karlsson MK, Wollmer
P, Andersen LB and Thorsson O: Cystatin B, cathepsin L and D
related to surrogate markers for cardiovascular disease in
children. PLoS One. 12:e01874942017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Farges MC, Balcerzak D, Fisher BD, Attaix
D, Béchet D, Ferrara M and Baracos VE: Increased muscle proteolysis
after local trauma mainly reflects macrophage-associated lysosomal
proteolysis. Am J Physiol Endocrinol Metab. 282:E326–E335. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stevenson EJ, Giresi PG, Koncarevic A and
Kandarian SC: Global analysis of gene expression patterns during
disuse atrophy in rat skeletal muscle. J Physiol. 551:33–48. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salminen A and Kihlström M: Lysosomal
changes in mouse skeletal muscle during the repair of exercise
injuries. Muscle Nerve. 8:269–279. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen D, Corina K, Chow EP, Miller S, Janmey
PA and Pepinsky RB: The plasma and cytoplasmic forms of human
gelsolin differ in disulfide structure. Biochemistry. 35:9700–9709.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rao J and Li N: Microfilament actin
remodeling as a potential target for cancer drug development. Curr
Cancer Drug Targets. 4:345–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao J, Qin Z, Guan X, Guo J, Wang H and
Liu S: Overexpression of GSN could decrease inflammation and
apoptosis in EAE and may enhance vitamin D therapy on EAE/MS. Sci
Rep. 7:6042017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bentzinger CF, Barzaghi P, Lin S and Ruegg
MA: Overexpression of mini-agrin in skeletal muscle increases
muscle integrity and regenerative capacity in
laminin-alpha2-deficient mice. FASEB J. 19:934–942. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hettwer S, Dahinden P, Kucsera S, Farina
C, Ahmed S, Fariello R, Drey M, Sieber CC and Vrijbloed JW:
Elevated levels of a C-terminal agrin fragment identifies a new
subset of sarcopenia patients. Exp Gerontol. 48:69–75. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brenner M, Johnson AB, Boespflug-Tanguy O,
Rodriguez D, Goldman JE and Messing A: Mutations in GFAP, encoding
glial fibrillary acidic protein, are associated with Alexander
disease. Nat Genet. 27:117–120. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scherbakov N, Knops M, Ebner N, Valentova
M, Sandek A, Grittner U, Dahinden P, Hettwer S, Schefold JC, von
Haehling S, et al: Evaluation of C-terminal agrin fragment as a
marker of muscle wasting in patients after acute stroke during
early rehabilitation. J Cachexia Sarcopenia Muscle. 7:60–67. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Watson CJ, Ledwidge MT, Phelan D, Collier
P, Byrne JC, Dunn MJ, McDonald KM and Baugh JA: Proteomic analysis
of coronary sinus serum reveals leucine-rich α2-glycoprotein as a
novel biomarker of ventricular dysfunction and heart failure. Circ
Heart Fail. 4:188–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huzé C, Bauché S, Richard P, Chevessier F,
Goillot E, Gaudon K, et al: Identification of an agrin mutation
that causes congenital myasthenia and affects synapse function. Am
J Hum Genet. 85:155–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bentzinger CF, Barzaghi P, Lin S and Ruegg
MA: Overexpression of mini-agrin in skeletal muscle increases
muscle integrity and regenerative capacity in
laminin-alpha2-deficient mice. FASEB J. 19:934–942. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goodpaster BH, Kelley DE, Thaete FL, He J
and Ross R: Skeletal muscle attenuation determined by computed
tomography is associated with skeletal muscle lipid content. J Appl
Physiol (1985). 89:104–110. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ramage MI, Johns N, Deans CD, Ross JA,
Preston T, Skipworth RJ, Jacobi C and Fearon KC: The relationship
between muscle protein content and CT-derived muscle radio-density
in patients with upper GI cancer. Clin Nutr. 37:752–754. 2018.
View Article : Google Scholar : PubMed/NCBI
|
